ID

12870

Descrição

Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00942318

Link

https://clinicaltrials.gov/show/NCT00942318

Palavras-chave

  1. 04/01/2016 04/01/2016 -
Transferido a

4 de janeiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Type 2 Diabetes Mellitus NCT00942318

Eligibility Type 2 Diabetes Mellitus NCT00942318

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Descrição

diabetes mellitus type 2

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
age > 18 years
Descrição

ID.2

Tipo de dados

boolean

patients treated for at least 6 months by multiple daily insulin injections associating long acting insulin (at least 1 long acting insulin analog injection-glargine or detemir- or at least 2 nph insulin injections) plus mealtimes rapid acting insulin injections (human or analogs) +/- oral hypoglycemic agents.
Descrição

long acting insulin; rapid acting insulin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0304870
UMLS CUI [2]
C0356365
7,5% ≤ hba1c ≤ 10%
Descrição

hba1c

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019018
patients able to perform self-monitoring blood glucose (smbg) measurement and insulin injections.
Descrição

Blood Glucose Self-Monitoring

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005803
smbg > 3/day
Descrição

Blood Glucose Self-Monitoring

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005803
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
diabetic retinopathy contraindicating glycemic control intensification
Descrição

diabetic retinopathy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0011884
situation or pathology not allowing therapeutic education program (blindness, deafness, low language fluency…)
Descrição

Comorbidity Limited Compliance behavior

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1321605
situation or pathology not allowing insulin therapy self-management and / or portable insulin pump use (rheumatologic pathology, low visual acuity, …)
Descrição

Comorbidity Limited Compliance behavior

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1321605
recent (<3 month) serious pathology
Descrição

pathology

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0030664
planned treatment or therapy able to induce long-term glycemic control worsening
Descrição

Poor glycemic control

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0342299
long lasting (> 2 month) planned treatment with glucocorticoids, octreotide, lanreotide or danazol
Descrição

glucocorticoids; octreotide

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0028833
pregnancy wish or ongoing pregnancy
Descrição

pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0549206
known haemoglobinopathy.
Descrição

haemoglobinopathy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019045
creatinin clearance <30ml/min (mdrd formula).
Descrição

creatinin clearance

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
organ transplant.
Descrição

organ transplant

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0029216

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00942318

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
ID.2
Item
age > 18 years
boolean
long acting insulin; rapid acting insulin
Item
patients treated for at least 6 months by multiple daily insulin injections associating long acting insulin (at least 1 long acting insulin analog injection-glargine or detemir- or at least 2 nph insulin injections) plus mealtimes rapid acting insulin injections (human or analogs) +/- oral hypoglycemic agents.
boolean
C0304870 (UMLS CUI [1])
C0356365 (UMLS CUI [2])
hba1c
Item
7,5% ≤ hba1c ≤ 10%
boolean
C0019018 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
patients able to perform self-monitoring blood glucose (smbg) measurement and insulin injections.
boolean
C0005803 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
smbg > 3/day
boolean
C0005803 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
diabetic retinopathy
Item
diabetic retinopathy contraindicating glycemic control intensification
boolean
C0011884 (UMLS CUI [1])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing therapeutic education program (blindness, deafness, low language fluency…)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing insulin therapy self-management and / or portable insulin pump use (rheumatologic pathology, low visual acuity, …)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
pathology
Item
recent (<3 month) serious pathology
boolean
C0030664 (UMLS CUI [1])
Poor glycemic control
Item
planned treatment or therapy able to induce long-term glycemic control worsening
boolean
C0342299 (UMLS CUI [1])
glucocorticoids; octreotide
Item
long lasting (> 2 month) planned treatment with glucocorticoids, octreotide, lanreotide or danazol
boolean
C0017710 (UMLS CUI [1])
C0028833 (UMLS CUI [2])
pregnancy
Item
pregnancy wish or ongoing pregnancy
boolean
C0549206 (UMLS CUI [1])
haemoglobinopathy
Item
known haemoglobinopathy.
boolean
C0019045 (UMLS CUI [1])
creatinin clearance
Item
creatinin clearance <30ml/min (mdrd formula).
boolean
C0201976 (UMLS CUI [1])
organ transplant
Item
organ transplant.
boolean
C0029216 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial